Latest by Kevin J. Armington

Multdrug-Resistant HIV and Primary Infection: A New Threat to At-Risk Individuals, and a New Challenge for Care Providers

The next wave of the HIV epidemic has begun to roll over us. It has already hit the communities at highest risk -- men who have sex with men and intravenous-drug users living in areas where multi-drug antiretroviral therapy is now the standard of car...

By Kevin J. Armington for San Francisco General Hospital

Should You Participate in Clinical Trials?

Once there was only AZT. Now there are a dozen drugs that can be used to combat HIV, and new drugs are being developed, tested, and approved at an unprecedented rate. Last October the Food and Drug Administration approved Combivir®, the first two-in-...

By Kevin J. Armington for San Francisco General Hospital